Mar. 23 -- WEDNESDAY, Aug. 15 (HealthDay News) -- For the first time, scientists say they have identified an immune molecule that may predict prostate cancer recurrence after surgery. "We discovered a ...
The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback